• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Gene May Offer Target to Combat Parkinson’s Disease

  Healing Heart
 

Mouse neurons showing that loss of MUL1 in Parkinson’s disease model is detrimental to neuronal health. (Top) Neurons stained with indicator of mitochondrial health (red) show that loss of MUL1 in Parkinson’s disease model induces mitochondrial damage. (Bottom) Neurons visualized with GFP showing abnormal neuronal morphology and death in loss of both MUL1 and parkin.
Images: Courtesy of Dr. Ming Guo

UCLA researchers have identified a new gene involved in Parkinson’s disease, perhaps providing a target for drugs that could one day prevent, or even cure, the debilitating illness.

Ming Guo, MD (RES ’01, FEL ’02), PhD, associate professor of neurology and pharmacology, and her team were one of two groups in 2006 that first reported that two genes, PTEN-induced putative kinase 1 (PINK1) and parkin, act together to maintain the health of mitochondria, which power the neurons that are important for maintaining brain health. Mutations in these genes lead to early-onset Parkinson’s disease.

Dr. Guo’s team also showed that when the PINK1 and parkin genes are operating correctly, they help maintain the regular shape of healthy mitochondria and help cells eliminate damaged mitochondria. The accumulation of unhealthy or damaged mitochondria in neurons and muscles ultimately results in Parkinson’s disease.

In the new study, Dr. Guo and her colleagues found that a gene called MUL1 (also known as MULAN and MAPL) plays an important role in mediating the pathology of the PINK1 and parkin. The study, performed in fruit flies and mice, showed that providing an extra amount of MUL1 helps reduce the amount of damage that mutated PINK1/parkin create in mitochondria and that inhibiting MUL1 in mutant PINK1/ parkin exacerbates the damage to the mitochondria. In addition, Dr. Guo and her collaborators found that removing MUL1 from mouse neurons of the parkin disease model results in unhealthy mitochondria and degeneration of the neurons.

“We show that MUL1 dosage is key, and optimizing its function is crucial for brain health and to ward off Parkinson’s disease,” Dr. Guo says. “Our work proves that mitochondrial health is of central importance to keep us from suffering from neurodegeneration. Further, finding a drug that can enhance MUL1 function would be of great benefit to patients with Parkinson’s disease. This finding is a major advance in research into Parkinson’s disease.”

There are several implications to this work. MUL1 appears to be a promising drug target, “and it may constitute a new pathway regulating the quality of mitochondria,” Dr. Guo says. She and her team plan to test their results in more-complex organisms, hoping to understand more about how MUL1 works. The team also will work on identifying compounds that could specifically target MUL1 and examine whether or not mutations in MUL1 exist in some people with inherited forms of Parkinson’s.

MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin,” eLife, June 4, 2014


Previous
The Healing Heart
Next
The True Healthcare Costs of Undocumented Immigrants


YOU ARE VIEWING

Fall 2014

Fall 2014
E-Brochure
Printable PDF
IN THIS ISSUE
  • Toward a Bright Tomorrow
  • Surgery through the Lens of Google Glass
  • A Game-changer in the Fight against Melanoma
  • Ferric Factor
  • A Double Dose of Promising Lung-cancer Findings
  • The Healing Heart
  • Gene May Offer Target to Combat Parkinson’s Disease
  • The True Healthcare Costs of Undocumented Immigrants
  • Lost in Translation
  • Depression Increases Risk for Diabetic Seniors
  • Redesigning the Well-child Checkup
  • Change Agent
  • To Heal the Human Instrument
  • Finding the Right Path
  • At the End of Too-few Days
  • Front-line Physician
  • Awards/Honors
  • In Memoriam
  • Promoting Exchange to Encourage Change
  • 2014 Alumnus of the Year
  • In His Own Words: Kevin Teehee, MD ’97
  • Postcard from Mozambique
  • UCLA Bestows Highest Honor on Distinguished Philanthropists
  • UCLA Health Sciences Honors Robert Draine
  • Music Creates a Personal Evening
  • Art and Science Take Flight at the Space Shuttle Pavilion
  • Celebrity Poker Event Benefits Center for Duchenne Muscular Dystrophy at UCLA
  • Visionary Force Behind UCLA Pancreatic-Cancer Research
  • Chairs of Distinction
  • In Memoriam
  • Gifts
  • From Patient to Physician: A Personal Journey
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth